Setting the baseline to fight Gram-negative bacteraemia: the necessity of epidemiological insights

References

• Lye DC, Earnest A, Ling ML, et al. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study. Clin Microbiol Infect. 2012;18:502–508.
   PubMed Web of Science ®Google Scholar
• Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010;23:546–553.
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, Hoste E, et al. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa. J Hosp Infect. 2003;53:18–24.
   PubMed Web of Science ®Google Scholar
• Reynvoet E, Vandijck DM, Blot SI, et al. Epidemiology of infection in critically ill patients with acute renal failure. Crit Care Med. 2009;37:2203–2209.
   PubMed Web of Science ®Google Scholar
• Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care. 2008;14:189–197.
   PubMed Web of Science ®Google Scholar
• McCabe W, Jackson G. Gram-negative bacteremia. I. Arch Intern Med. 1962;110:847–855.
   Google Scholar
• Freid MA, Vosti KL. The importance of underlying disease in patients with Gram-negative bacteremia. Arch Intern Med. 1968;121:418–423.
   PubMed Web of Science ®Google Scholar
• Davis SD, Iannetta A, Wedgwood RJ. Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy. J Infect Dis. 1971;124:104–106.
   PubMed Web of Science ®Google Scholar
• Andriole VT. Pseudomonas bacteremia: can antibiotictherapy improve survival? J Lab Clin Med. 1979;94:196–200.
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, Colardyn F. Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis. 2002;21:471–473.
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, Hoste E, et al. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia. Infect Control Hosp Epidemiol. 2003;24:912–915.
   PubMed Web of Science ®Google Scholar
• Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003;54:258–266.
   PubMed Web of Science ®Google Scholar
• Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32:2014–2020.
   PubMed Web of Science ®Google Scholar
• Delle Rose D, Pezzotti P, Fontana C, et al. An in-depth analysis of nosocomial bloodstream infections due to Gram negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a one-year, prospective study in a large tertiary care Italian hospital. Infect Dis. 2018.
   Google Scholar
• Sousa AS, Ferrito C, Paiva JA. Intubation-associated pneumonia: an integrative review. Intensive Crit Care Nurs. 2018;44:45–52.
   PubMed Web of Science ®Google Scholar
• Galiczewski JM, Shurpin KM. An intervention to improve the catheter associated urinary tract infection rate in a medical intensive care unit: direct observation of catheter insertion procedure. Intensive Crit Care Nurs. 2017;40:26–34.
   PubMed Web of Science ®Google Scholar
• Arvaniti K. Preventing central venous line related bloodstream infections in adult ICUs: start from the basics and bundle. Intensive Crit Care Nurs. 2017;43:3–5.
   PubMed Web of Science ®Google Scholar
• Blot K, Bergs J, Vogelaers D, et al. Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis. Clin Infect Dis. 2014;59:96–105.
   PubMed Web of Science ®Google Scholar
• Powers J. Impact of an aseptic procedure for breaking the integrity of the urinary drainage system on the development of catheter-associated urinary tract infections in the intensive care unit. Intensive Crit Care Nurs. 2016;37:82–85.
   PubMed Web of Science ®Google Scholar
• Galiczewski JM. Interventions for the prevention of catheter associated urinary tract infections in intensive care units: an integrative review. Intensive Crit Care Nurs. 2016;32:1–11.
   PubMed Web of Science ®Google Scholar
• van der Kooi T, Sax H, Pittet D, et al. Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections. Intensive Care Med. 2018;44:48–60.
   PubMed Web of Science ®Google Scholar
• Afonso E, Blot K, Blot S. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials. Euro Surveill. 2016;21:30400.
   PubMedGoogle Scholar
• Bonten MJM, Mascini EM. The hidden faces of the epidemiology of antibiotic resistance. Intensive Care Med. 2003;29:1–2.
   PubMed Web of Science ®Google Scholar
• Zahar J-R, Blot S. Dilemmas in infection control in the intensive care unit. Intensive Crit Care Nurs. 2018;46:1.
   PubMed Web of Science ®Google Scholar
• De Wandel D. Key factors for hand hygiene promotion in intensive care units. Intensive Crit Care Nurs. 2017;42:3–4.
   PubMed Web of Science ®Google Scholar
• Valencia C, Hammami N, Agodi A, et al. Poor adherence to guidelines for preventing central line-associated bloodstream infections (CLABSI): results of a worldwide survey. Antimicrob Resist Infect Control. 2016;5:49.
   PubMed Web of Science ®Google Scholar
• Sandiumenge A, Diaz E, Bodí M, et al. Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of “The Tarragona Strategy”. Intensive Care Med. 2003;29:876–883.
   PubMed Web of Science ®Google Scholar
• Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect. 2008;14:5–13.
   PubMed Web of Science ®Google Scholar
• Brusselaers N, Labeau S, Vogelaers D, et al. Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med. 2013;39:365–375.
   PubMed Web of Science ®Google Scholar
• Depuydt P, Benoit D, Vogelaers D, et al. Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med. 2006;32:1773–1781.
   PubMed Web of Science ®Google Scholar
• Vogelaers D, De Bels D, Forêt F, et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates–a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents. 2010;35:375–381.
   PubMed Web of Science ®Google Scholar
• Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs. 2003;63:2157–2168.
   PubMed Web of Science ®Google Scholar
• Blot SI, Vandewoude KH, Colardyn FA. Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study. Chest. 2003;123:1208–1213.
   PubMed Web of Science ®Google Scholar
• Daitch V, Akayzen Y, Abu-Ghanem Y, et al. Secular trends in the appropriateness of empirical antibiotic treatment in patients with bacteremia: a comparison between three prospective cohorts. Eur J Clin Microbiol Infect Dis. 2018;37:455–462.
   PubMed Web of Science ®Google Scholar